FATE THERAPEUTICS INC
Cash Flow Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||
| Net Income | $-43.0M | $-33.5M | $-30.0M | $-25.9M | $-20.9M | $-14.2M | $-13.4M |
| Depreciation & Amortization | $971.0K | $881.0K | $687.0K | $496.0K | $571.0K | $590.0K | $672.0K |
| Depreciation | — | — | — | — | — | — | — |
| Amortization | — | — | — | — | — | — | — |
| Stock-Based Compensation | — | — | $2.4M | $2.4M | $1.6M | $155.0K | $172.0K |
| Net Cash from Operating Activities | $-36.8M | $-29.8M | $-18.4M | $-22.4M | $-15.4M | $-13.3M | $-12.1M |
| Investing Activities | |||||||
| Capital Expenditures | $1.7M | $457.0K | $1.5M | $882.0K | $244.0K | $709.0K | $2.0K |
| Business Acquisitions | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $-10.2M | $-4.1M | — | — | — | — | — |
| Financing Activities | |||||||
| Dividends Paid | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | $7.0K |
| Net Cash from Financing Activities | $47.4M | $57.7M | — | — | — | — | — |
| Net Change in Cash | $343.0K | $23.8M | $15.7M | $-4.9M | $44.9M | $2.7M | $-4.8M |
| Free Cash Flow | $-38.5M | $-30.3M | $-19.9M | $-23.3M | $-15.6M | $-14.0M | $-12.1M |